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PURPOSE. To assess the range of macular pigment optical density (MPOD) in a healthy group of
young adults of South Asian origin; to investigate whether any dietary factors or personal
characteristics were related to intersubject variations in MPOD; and to compare the mean
MPOD of the South Asian group with the mean MPOD of a white group.
METHODS. Heterochromatic flicker photometry was used to measure the macular pigment
(MP) levels of 169 healthy volunteers, of which 117 were Asian and 52 were white. In
addition, the Asian participants completed a questionnaire pertaining to the various physical,
ocular, lifestyle, dietary, and environmental factors that may be associated with MPOD or
AMD.
RESULTS. The mean MPOD of the Asian subjects was 0.43 6 0.14. The male participants had a
higher mean MPOD than the females (0.47 6 0.13 vs. 0.41 6 0.14, P < 0.01). Possible
associations also emerged between MPOD and form of refractive correction, and iris color. No
MPOD associations were found for the other variables examined in the questionnaire. The
mean MPOD of the white subject group was 0.33 6 0.13, which was significantly lower than
the Asian group (P < 0.0005).
CONCLUSIONS. This study adds to the currently limited information on MPOD in South Asians,
and while a comparison between Asians and Whites was not the main focus here, highly
significant differences between these two ethnicities were revealed. This provokes the
possibility that South Asian individuals could have a lower risk for AMD, and it warrants
further study.
Keywords: age-related macular degeneration, heterochromatic flicker photometry, macular
pigment, macular pigment optical density
Evidence suggests that ethnicity has a role to play in AMD,with Whites having the highest prevalence and Blacks the
lowest.1–13 The AMD prevalence in East Asians (Chinese/
Japanese), Southeast Asians (Malays), Hispanics, and Latinos has
mostly been found to be lower than in Whites, but higher than
in Blacks.14–21 Studies on South Asians (Indians/Pakistanis/
Bangladeshis/Sri Lankans) have been rare, but reported
prevalences in a North and South Indian population were
comparable to Western countries.22–24 Cheung and colleagues
determined the prevalence of AMD in Chinese, Malay, and
Indian persons in Singapore25 and found it to be similar
between the three groups. Based on pooled data from Kawasaki
et al.,26 they concurred with the previous reports that
prevalence is similar to Whites.
Macular pigment (MP) is the collective name for three
carotenoids, lutein (L), zeaxanthin (Z), and meso-zeaxanthin
(MZ), which are found at high concentrations in the central
macula, to the exclusion of other carotenoids.27 They are only
available through dietary/supplement intake.28,29 MP is a blue
light filter; its absorption spectrum peaks around 460 nm.30–33
It is well placed in the retina to reduce the amount of blue light
reaching the photoreceptors; the higher the MP optical density
(MPOD), the greater the amount of blue light filtering.34,35 It is
also proposed that MP protects against oxidative stress.36,37
Since blue light and oxidative stress have been implicated in the
pathogenesis of AMD,38,39 a high level of MP could reduce the
risk for AMD.40–43
The relationship between race and MPOD has been rarely
examined, largely because the vast majority of participants in
MPOD studies have been white. Wolf-Schnurrbusch et al.44
compared MPOD in a group of 51 African and 67 white non-
Hispanic subjects. The mean MPOD for the African subjects
was significantly higher than for the white subjects (P <
0.0001). Conversely, Iannaccone et al.45 compared MPOD in a
group of 35 black and 148 white subjects, and found it to be
significantly higher in the Whites than Blacks (P < 0.0005).
Nolan et al.46 compared 18 nonwhite (Indian, ‘‘Asian,’’
Hispanic, and black) and 41 white subjects; mean MPOD was
significantly higher in the nonwhite group than the white
group (P < 0.01). Studies that found no statistically significant
MPOD ethnicity differences47,48 had low numbers of nonwhite
subjects (7%–8% of total samples) compared with white
subjects, so there may have been a lack of statistical power.
Outside of ethnic comparisons and white subject–dominat-
ed MP studies, there have been a few MP investigations with
East Asian participants,49–52 and one with South Asian
participants.53
The aims of the current study were firstly to assess MPOD in
a healthy group of young adults of South Asian origin. Secondly,
to investigate whether any dietary factors or personal
characteristics were related to intersubject variations in MPOD.
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Thirdly, to compare, for the first time to our knowledge, the
mean MPOD of a South Asian group with that of a white group.
Hereafter, the term ‘‘South Asian’’ is shortened to ‘‘Asian,’’ and
is not intended to encompass any other Asian groups.
METHODS
Subjects
Subjects were recruited by email and word of mouth, and
consisted mainly of optometry students and staff from Aston
University. One hundred and twenty Asian subjects were
examined. The majority (104) were British born, 14 were
Canadian, and two were African. All were in good health, with
an age range of 18 to 30 years (mean 6 SD: 21.3 6 2.6 years).
MP measurements were also collected on 53 white partic-
ipants; 47 were British, two were Canadian, and the others
Australian, German, Irish, and Polish. All were in good health,
with an age range of 18 to 61 years (mean 6 SD: 27.6 6 9.3
years). The white subjects were not age-matched to the Asian
subjects.
All participants had a habitual visual acuity (VA) of 0.14
logMAR (Snellen 6/7.52) or better in the eye being tested (the
right eye unless it was unsuitable through poor acuity).
Exclusion criteria were: age younger than 18 years; VA worse
than 0.2 logMAR (Snellen 6/9.5) in the eye being tested; and
the presence of any ocular disease in the eye being tested (all
subjects were required to have had an eye examination within
the last year).
Aston University’s ethics committee approved the study. All
subjects signed an informed consent form, and all procedures
adhered to the tenets of the Declaration of Helsinki.
Lifestyle Questionnaire
A questionnaire was created for the Asian participants to
complete. Questions were focused on the physical, ocular,
lifestyle, dietary, and environmental factors that may be
associated with MPOD or AMD, for example, height and
weight (for body mass index [BMI] calculation), iris color,
smoking history, fruit/vegetable consumption, sunlight expo-
sure, and family history of AMD. A copy of the questionnaire is
provided as Supplementary Material.
Macular Pigment Screener (MPS) 9000
Measurements of MPOD were taken using the MPS 9000 (MPS-
Tinsley Ophthalmic, Redhill, Surrey, UK), a portable device
that employs the heterochromatic flicker photometry (HFP)
technique, and which has been described in detail else-
where.54 In brief, HFP determines MPOD by presenting a light
stimulus of two alternating wavelengths (blue, maximal
absorption by MP, and green/yellow, minimal absorption by
MP) at the fovea and at a parafoveal or perifoveal area, with the
aim of achieving a perception of no or minimal flicker. In
traditional HFP the blue-green alternation frequency remains
constant, while the radiance of the blue light is increased/
decreased until minimal flicker is reported. The procedure is
carried out with the subject looking directly at the stimulus
(central/foveal measure), and then away from the stimulus
(peripheral measure, where MP is assumed to be negligible).
The presence of MP in the fovea (with subsequent absorption
of some of the blue light before it reaches the photoreceptors)
means that a greater radiance of blue light is required here for
minimal flicker than at the eccentric point. The log ratio of the
two values gives a measure of MPOD. The MPS uses the same
HFP principle, but instead of responding to minimal flicker,
subjects respond to the appearance of flicker as the blue-green
alternation frequency decreases automatically.54 Rather than
the radiance of the blue wavelength light being adjusted by the
subject until minimal flicker, the subject registers their first
perception of flicker throughout a series of blue-green ratios.
Over the course of the test their responses create two V-
shaped curves that are visible on a computer screen. One
curve represents central viewing of a 18 circular stimulus, and
the other peripheral viewing (88 eccentricity). An internal
algorithm calculates the MPOD using the difference between
the central and peripheral minima (the larger the difference,
the higher the MPOD), but this can also be calculated manually.
An explanation of how to perform the MPS test was read by
the investigator from an instruction sheet. Subjects wore their
habitual distance correction, if appropriate, and the eye not
being measured was occluded. Each subject performed two
central and peripheral tests (a short practice was completed
before the first of each). Because the MPS generates a visible
curve as subjects respond to flicker, it provides a way for the
operator to assess whether the curve adheres to the expected
V-shape, giving an indication as to the accuracy of the MPOD
value produced. The results were, therefore, screened at the
time of data collection, and if a poor curve was obtained, or if
there was a considerable difference between equivalent
minimum readings (central or peripheral), then a third central
and/or peripheral test was completed. The averages of the
central minima and peripheral minima were used to calculate
MPOD. Any poor quality curves were not included in the
MPOD calculation. This method has been shown to provide
excellent repeatability in subjects of similar ages to this study.55
Total testing time was 10 to 20 minutes per subject.
The main focus of this study was to examine an Asian
subject group, and the numbers recruited were in line with
several other MPOD studies that each examined a host of
variables and their possible associations with MPOD.44,56–58 In
addition, power calculations, using G*Power (version 3.1;
Heinrich-Heine University, Du¨sseldorf, Germany), indicated
that for an estimated significant mean difference in MPOD of
0.1 (with group SDs of 0.14), a sample size of 64, with 32
subjects per group, was required for 80% power at the 5%
alpha significance level.
Statistics
SPSS (version 18.0; IBM, Portsmouth, UK) was used for data
analysis. Mean values were mainly compared using two-tailed
independent-samples t-tests or its nonparametric equivalent
(the Mann-Whitney U test), as appropriate in terms of
normality. Pearson’s r or Spearman’s rho correlations were
used to quantify associations between continuous variables. A
P value of less than 0.05 was considered statistically significant.
RESULTS
Lifestyle Questionnaire
Data from three Asian subjects were removed from the
analyses due to inability to complete the MPS test. Of the
remaining 117 participants with successful MPOD measure-
ments, 100 fully completed the lifestyle questionnaire, and one
subject partially completed it. Only limited information was
available for the 16 other subjects. See Table 1 for descriptive
statistics of the Asian group.
The mean MPOD of 117 Asian subjects was 0.43 6 0.14.
Other mean MPOD values on which statistical analyses were
conducted are summarized in Table 1. Some variables were not
analyzed because of the very low subject numbers in one or
more of the groups involved. These included: Asian back-
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grounds other than Indian and Pakistani, smoking status, sun-
bed use, and family history of AMD. For the same reason, some
variables were modified: iris colors other than dark brown were
combined to make a larger group that could then be compared
with dark brown; part vegetarians were excluded from the
dietary background analysis; and the ‘mixture’ group was
excluded from the refractive correction analysis.
Of the variables examined, only sex demonstrated a
statistically significant difference in MPOD, with the males
having a higher average MPOD than the females (P ¼ 0.008).
Figure 1 shows the frequency distribution of MPOD for both
groups.
Aside from sex, another variable that approached signifi-
cance (P ¼ 0.059) was refractive correction; individuals who
wore spectacles (which absorb some or all UV light) or UV-
filtering contact lenses (CLs) full time had a higher mean MPOD
than those who wore no spectacles or non–UV-filtering CLs
(Table 1). There was also a possible trend for iris color; subjects
with dark brown eyes had a higher mean MPOD than subjects
with lighter (‘‘other’’) eyes (P¼0.078). The spread of MPOD in
these two groups is shown in Figure 2. Table 2 shows the
individual MPOD breakdown of the more unusual iris colors in
the non–dark brown category (unusual, that is, for an Asian
population), so brown irides, which accounted for the largest
percentage eye color in this group, have been omitted. All but
one MPOD value was below the overall average of 0.43 6 0.14
and below the ‘‘other’’ iris color group’s average of 0.41 6 0.13.
In addition to looking for differences in mean MPOD
between the various groups, the possibility of any MPOD
associations was explored for the continuous data. Using
Pearson’s r or Spearman’s rho (dependent on normality), and
TABLE 1. A Summary of the Physical, Ocular, Lifestyle, Dietary, and
Environmental Data Collected on the Asian group, Along With the
Corresponding MPOD
Variable Value MPOD
All, n 117 0.43 6 0.14
Age, y 21.3 6 2.6 N/A
Sex, n
Male 44 (38%) 0.47 6 0.13
Female 73 (62%) 0.41 6 0.14*
BMI
All 21.9 6 4.0 (n ¼ 100) N/A
Male 23.8 6 4.6 (n ¼ 38) N/A
Female 20.8 6 3.1 (n ¼ 62) N/A
South Asian origin, n
Indian 75 (71%) 0.44 6 0.15
Pakistani 22 (21%) 0.42 6 0.12
Bangladeshi 3 (3%) N/A
Sri Lankan 4 (4%) N/A
Other 2 (2%) N/A
Iris color, n
Dark brown 61 (58%) 0.46 6 0.15
Brown 37 (35%) 0.42 6 0.14
Light brown 1 (1%) N/A
Hazel 5 (5%) N/A
Green 2 (2%) N/A
Brown þ light brown
þ hazel þ green 45 (42%) 0.41 6 0.13
Smoking status, n
Current 6 (6%) N/A
Former 3 (3%) N/A
Never 92 (91%) N/A
Dietary background, n
Meat eater 72 (71%) 0.43 6 0.13
Part vegetarian† 8 (8%) N/A
Vegetarian 21 (21%) 0.46 6 0.16
Vegetable servings per wk 7.0 6 5.2 (n ¼ 100) N/A
Fruit servings per wk 6.6 6 5.8 (n ¼ 100) N/A
Eggs (including yolks) per wk 1.8 6 2.1 (n ¼ 100) N/A
15 vegetable þ fruit þ egg
servings per wk 59 (59%) 0.44 6 0.13
>15 vegetable þ fruit þ egg
servings per wk 41 (41%) 0.44 6 0.15
Oily fish servings per wk 0.7 6 1.1 (n ¼ 101) N/A
Alcohol units per wk 3.8 6 8.2 (n ¼ 101) N/A
Regular exercise, n
Yes 44 (44%) 0.43 6 0.13
No 57 (56%) 0.44 6 0.15
Time spent outside per wk, h
Autumn/winter 8.7 6 5.8 (n ¼ 100) N/A
Spring/summer 17.0 6 10.0 (n ¼ 100) N/A
Autumn/winter daylight
exposure  7 h 56 (56%) 0.43 6 0.14
Autumn/winter daylight
exposure > 7 h 44 (44%) 0.44 6 0.15
Spring/summer daylight
exposure  15 h 52 (52%) 0.43 6 0.13
Spring/summer daylight
exposure > 15 h 48 (48%) 0.44 6 0.15
Regular strong sunlight exposure, n
Yes 24 (24%) 0.43 6 0.13
No 77 (76%) 0.44 6 0.15
TABLE 1. Continued
Variable Value MPOD
Sunbed use, n
Yes 1 (1%) N/A
No 100 (99%) N/A
Skin sensitivity to sunlight, n
Yes 12 (12%) 0.46 6 0.11
No 89 (88%) 0.43 6 0.14
Sunglasses use in bright conditions, n
Always/most of the time 19 (19%) 0.40 6 0.16
Sometimes/occasionally 39 (39%) 0.43 6 0.13
Very rarely/never 43 (43%) 0.45 6 0.14
Spectacle prescription
– best vision sphere, DS 2.08 6 2.82 (n ¼ 110) N/A
Refractive correction, n
Spectacles and/or UV-blocking
contact lenses 39 (37%) 0.47 6 0.15
None or non–UV-blocking
contact lenses 62 (59%) 0.42 6 0.14
Mixture 4 (4%) N/A
Family history of AMD, n
Yes 2 (2%) N/A
No 99 (98%) N/A
Note: Information on vitamin and supplement use was also
acquired from the questionnaire, but it is not included here as very
few subjects took either, and of those that did, no vitamins/
supplements included lutein or zeaxanthin. N/A, not applicable.
* P < 0.01 (i.e., male MPOD significantly higher than female
MPOD).
† Part vegetarian refers to someone who eats one form of meat only
(e.g., fish).
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scatter graph observations, virtually no significant correlations
between MPOD and any variable (age, BMI, vegetable intake,
fruit intake, vegetables/fruits combined, egg intake, vegetables/
fruits/eggs combined, oily fish intake, alcohol intake, hours
spent outside, and best vision sphere) were found, even when
analyzing males and females separately (in view of the MPOD
sex difference). The only significant correlation to emerge was
a positive association between MPOD and alcohol intake (rho¼
0.229, P ¼ 0.021). This association remained significant for
females (rho ¼ 0.330, P ¼ 0.009), but not for males (rho ¼
0.108, P ¼ 0.511). However, observation of the scatter graphs
indicated that the large proportion of subjects who did not
drink alcohol (61%) might have influenced the correlations.
Indeed, separating the group as a whole into drinkers of
alcohol and nondrinkers resulted in no relationship for alcohol
units and MPOD (rho ¼ 0.045, P ¼ 0.782).
Asian Versus White MPOD Comparisons
Data from one white subject was removed from the analyses
due to inability to complete the MPS test. The total number of
Whites was 52 (15 males, 37 females), and their mean MPOD
was 0.33 6 0.13, compared with 0.43 6 0.14 for the 117 Asian
subjects. These means are significantly different (P < 0.0005),
as demonstrated in Table 3. Figure 3 is a frequency distribution
of MPOD for each group. The white group was older than the
Asian group, on average, and a significant decline in MPOD
with age was present in this particular sample (Fig. 4), which
could therefore be the cause of the differing MPOD means
FIGURE 1. The frequency distribution of MPOD for males and females in the Asian group.
FIGURE 2. The frequency distribution of MPOD for individuals with dark brown eyes and other colored eyes (brown, light brown, hazel, green) in
the Asian group.
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between the two races. Although there was still a difference in
the mean ages (P ¼ 0.01), limiting the white subjects to the
same age range as the Asian subjects (18–30 years, n ¼ 39
Whites) removed the MPOD age correlation (rho¼0.135, P¼
0.413), but a statistically significant difference between the
two MPOD means (P¼ 0.002) was maintained. Finally, MPOD
in the white group was examined for any sex differences. In
contrast to the Asians, the mean MPOD in males (0.30 6 0.14)
was lower than the mean MPOD in females (0.34 6 0.13), but
this difference was not statistically significant (P ¼ 0.385).
DISCUSSION
The present investigation aimed to determine the range of
MPOD in a healthy group of young adults of South Asian origin,
to investigate whether any dietary factors or personal
characteristics were related to intersubject variations in MPOD,
and to compare the mean MPOD of a South Asian group with
that of a white group.
The mean MPOD of the Asian subjects was higher than
most previously published MPS-based averages,54,59–64 the
exceptions being the MPOD means reported by Qin et al.65
and Tsika et al.66 (0.47 and 0.52, respectively). While not being
directly comparable (because of the different HFP instruments
used), Raman et al. also reported a high MPOD mean of 0.50 6
0.21 at 0.58 in their group of South Asian subjects.53 It
therefore seems very likely that South Asians have higher MP
levels, on average, than other, predominantly white, subjects,
although we recognize that none of our particular population
sample were born in Asia, and so may not be representative of
South Asians in general. However, it is still useful to know if
people of South Asian origin living in developed countries have
higher MPOD, as they may have less chance of AMD, which is
important in terms of AMD screening in developed countries,
and also in terms of planning public health expenditure.
We found Asian males averaged a statistically significant
higher mean MPOD than females. This finding is in common
with several other studies,34,43,56,61,67–72 while the converse
has been rarely reported.58 Nevertheless, the majority of
studies have not found any sex differences, and in the present
study the effect size (r ¼ 0.25) was only small to medium. Of
note, Raman et al., in their MPOD study of South Asians,
reported higher MPOD in males (0.54 6 0.14, n ¼ 30) than
females (0.47 6 0.18, n ¼ 30) in their participant age group
(20–29) similar to the present study, but this difference was not
statistically significant (P ¼ 0.087).53
Aside from the male/female difference, MPOD in the
present study was unrelated to virtually all the physical,
ocular, lifestyle, dietary, and environmental factors determined
from the questionnaire. In some cases this could, in part, be
the result of too small a sample size, such as the limited
number of vegetarians compared with meat eaters. It may also
be due to problems inherent in our data collection methods,
such as relying on self-reported height and weight to calculate
BMI.
There was an almost significant MPOD difference between
individuals who wore spectacles or UV-filtering CLs full time
and those who wore no spectacles or non–UV-filtering CLs.
These differences were not attributable to greater numbers of
males in the spectacle/UV CL group (36% males/64% females)
compared with the no spectacles/non-UV CL group (42%
males/58% females). We previously reported significantly
greater MPOD (P ¼ 0.014) in eyes that had worn UV-blocking
CLs (0.41 6 0.13) compared with eyes that had worn non–UV-
blocking CLs (0.33 6 0.15) for the previous 5 years.97 Light
exposure, particularly UV and blue light, is damaging to the
retina,73–76 and it has been shown to cause the production of
free radicals, leading to oxidative stress and possibly AMD.39
From population-based studies, there is some evidence to
suggest that chronic light exposure is a risk factor for
AMD.77–79 With less UV light reaching the retina as a result
of absorption by spectacles or UV CLs, there may be less light-
induced oxidative stress in the retina, thus, permitting an
augmentation of MP by reducing its antioxidant-function
workload. Interestingly, there was no MPOD relationship with
questionnaire-reported sunglasses use or light exposure. This
could be because sunglasses are mostly worn in bright
conditions (and the questionnaire only asked about their use
in bright conditions), so the UV protection is intermittent.
Spectacles and CLs would be worn more often, out of necessity
to see clearly (and the questionnaire asked specifically about
the frequency of spectacle/CL wear and their use in public), so
chronic exposure to UV light would be less than with
sunglasses. Furthermore, it has been documented that high
MPODs are associated with better glare resistance.80–83 As a
result, those with higher MPOD may feel less inclined to wear
sunglasses. Although not reaching statistical significance, this
could explain the higher MPOD means in those subjects
reporting very little sunglasses use compared with those
reporting frequent use (Table 1). For light exposure, the
questions on time spent outdoors were far and above the ones
that participants struggled with the most, so the lack of any
significant correlation may in part be a reflection of the overall
difficulties in establishing an individual’s light exposure.
A comparison between Asians and Whites was not the main
focus of this study, and, therefore, the data interpretation is
limited in this respect. It is interesting, nonetheless, that in
comparing the Asian MPOD mean with the white MPOD mean,
highly significant differences were revealed (Asian MPOD
higher than white MPOD), regardless of age restrictions (Table
3). Even though there was still some MP overlap between the
two groups (Fig. 3), and a lot of variation left unexplained (the
effect size, r, was 0.35, i.e., a medium effect), the difference
was clear. The low fruit and vegetable consumption of the
Asian group suggests that this difference is unlikely to be the
result of dietary factors, although without such data available
for the white subjects, this clearly cannot be confirmed. It also
seems unlikely that sex differences between the groups would
be a factor, because the ratio of males to females in each group
TABLE 3. MPOD Comparisons Between the Asian and White Groups
Variable Asian Group White Group
MPOD 0.43 6 0.14 (n ¼ 117) 0.33 6 0.13 (n ¼ 52)*
Age, y 21.3 6 2.6 (n ¼ 117) 27.6 6 9.3 (n ¼ 52)*
Age, 18 to 30 y 21.3 6 2.6 (n ¼ 117) 23.2 6 3.6 (n ¼ 39)†
MPOD, 18 to 30 y 0.43 6 0.14 (n ¼ 117) 0.35 6 0.14 (n ¼ 39)‡
* P < 0.0005.
† P < 0.01.
‡ P < 0.005.
TABLE 2. The Individual MPOD Values of the Eight Asian Subjects With
Iris Colors Other Than Dark Brown or Brown
Iris Color MPOD Sex
Light brown 0.36 Male
Hazel 0.58 Male
Hazel 0.26 Female
Hazel 0.30 Female
Hazel 0.35 Female
Hazel 0.38 Female
Green 0.31 Female
Green 0.36 Female
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was similar, and comparison tests demonstrated significant
MPOD differences even when each sex was considered
separately (P < 0.0005 for males, P < 0.005 for females). It,
therefore, seems reasonable to assume that the cause lies
elsewhere.
Firstly, various aspects of foveal architecture have been
associated with MPOD. For instance, Nolan et al.46 found
MPOD to be positively and significantly correlated with foveal
width (r ¼ 0.41, P ¼ 0.001), and moreover, that the foveas of
non-Whites (Indian/Asian/Hispanic/black) were significantly
wider than the foveas of Whites (P < 0.05). Consequently, it is
possible that ethnic variations in foveal architecture could be a
reason for the disparity in MPOD, at least in part. From this
point of view, it would have been useful to know the spatial
profile of MP for the study participants, but we could not
measure this with the MPS.
Secondly, iris color, or more specifically melanin, could
account for the differences in MPOD between the two groups.
Like MP, melanin absorbs short-wavelength light (mainly UV)
and has antioxidant properties. In the iris its function is
predominantly the former, and in the retinal pigment
epithelium and choroid its function is predominantly the
latter.84 Light irides, which contain less melanin than dark
irides, have been identified as a risk factor for AMD,4,85–89 and
a risk factor for low MP,34,47,56,68,83,90–92 so in an ethnic group
where the majority of irides are dark, it seems logical that they
might have higher levels of MP (and a lower risk for AMD)
than an ethnic group with a mixture of light and dark iris
colors. On account of the expected high propensity of dark
irides in the Asian subjects, an eye color related MPOD
difference within this group was not anticipated, but it was
split into a ‘‘dark brown’’ and an ‘‘other’’ category, and
although not reaching statistical significance, there did appear
to be a trend towards the darker brown eyes having higher
MPOD. Iris color in this study, as in others,34,56,90 was self-
reported and not verified, so the fact that a difference may
exist between two such subtle iris color groups lends support
to the theory of melanin being involved with MPOD
differences between racial groups. In order to rule out the
possibility of a greater male dominance in the dark brown than
the ‘‘other’’ iris group (with subsequent higher MPOD being
the result of sex rather than eye color), the means were
compared separately. For males, the difference became more
insignificant, dark brown mean (n¼ 24): 0.47 6 0.12, ‘‘other’’
mean (n¼ 16): 0.48 6 0.13 (P¼ 0.707). For females, however,
the difference became statistically significant, dark brown
mean (n ¼ 37): 0.45 6 0.16, ‘‘other’’ mean (n ¼ 29): 0.37 6
0.12 (P¼ 0.021). After exploring this further, by examining the
individual MPODs of those subjects with more unusual iris
colors, it was striking that all but one MPOD value was well
below the overall Asian MPOD average and below the ‘‘other’’
iris color group’s MPOD average. It, therefore, seems highly
plausible that iris color is a cause of the racial differences in
mean MPOD observed in this study. By filtering out more light
than lighter colored eyes, dark eyes could reduce the amount
of harmful wavelengths reaching the retina,47,84 and as a
result, there might be a lowering of oxidative stress and less
depletion of MP than in lighter eyes. Another possibility, as
suggested by Hammond et al.,47 is that melanin and MP
deposition are co-inherited traits.
FIGURE 3. The frequency distribution of MPOD in the Asian and white subjects.
FIGURE 4. The relationship between age and MPOD for the white
subjects (Spearman’s rho ¼0.357, P ¼ 0.009).
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A final rationale for racial differences in MPOD could lie in
ethnicity-variant genetics besides melanin, but the possibilities
in this respect are highly diverse. For example, there might be
ethnic variations in how effectively L and Z are absorbed,
transported or deposited, or there could be specific genes/
alleles that lead to higher or lower MPOD, or indeed the first
example could be the result of the second. Twin studies on
MPOD have demonstrated that there is definitely a genetic
component involved,93,94 and a spousal-based MPOD study
appeared to confirm this also; despite statistically significant
correlations for dietary and blood serum levels of L and Z
between married couples, MPOD between husbands and wives
was not correlated at all.95 Recently a specific gene and its
respective genotypes were examined as part of an MPOD
study; Loane et al.96 compared MPOD in three different
genotype groups of the apolipoprotein E gene, a gene that
codes for lipoproteins that may carry L and Z in serum. It was
found that subjects in one of the genotype groups, which
contained at least one specific allele, had significantly higher
MPOD than subjects in the other two groups, which were both
without the specific allele. (As described by Loane et al., the
allele in question, Apo e4, has also been shown to reduce the
risk for AMD). This confirms again the genetic aspect of MP,
which is not unexpected given the still large amount of
unexplained intersubject MPOD variation in the current study
and many previous ones.
In conclusion, MPOD in this group of young adults of South
Asian origin was largely unrelated to any physical, ocular,
lifestyle, dietary, or environmental factors. Males and females,
however, did have significantly different MPOD levels, and
compared with a group of Whites, MPOD was significantly
higher in the Asians, which in turn could mean a decreased risk
for AMD. As demonstrated in the introduction, though, current
information on AMD prevalence in South Asians, particularly
with respect to comparisons with Whites, is limited. Future
research will hopefully address this, and wider scale studies
examining and comparing MPOD in different racial groups,
including South Asians, would be desirable.
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